Zoledronic acid (ZA) prevents aromatase inhibitor (Al)-associated bone loss in postmenopausal women with early breast cancer -36-month follow-up of the Z-FAST study
A. Brufskv, L. Bosserman, R. Caradonna, B. Haley, M. Jones, H. Moore, M. Dong, G. Warsi, S. Ericson, E. PerezVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70810-3
File:
PDF, 61 KB
english, 2008